✦ LIBER ✦

A predictive value of quantitative HBsAg for serum HBV DNA level among HBeAg-positive pregnant women

✍ Scribed by Kui-Xia Sun; Jie Li; Feng-Cai Zhu; Jian-Xun Liu; Rong-Cheng Li; Xiang-Jun Zhai; Yan-Ping Li; Zhan-Jun Chang; Jing-Jing Nie; Hui Zhuang

Book ID: 115542159
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 404 KB
Volume: 30
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2012.06.036

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum ALT Levels as a Surrogate Marker f

Serum ALT Levels as a Surrogate Marker for Serum HBV DNA Levels in HBeAg-negative Pregnant Women

✍ Sangfelt, Per; Von Sydow, Madeleine; Uhnoo, Ingrid; Weiland, Ola; Lindh, Gudrun; 📂 Article 📅 2004 🏛 Informa plc 🌐 English ⚖ 79 KB

A low proportion of HBeAg among HBsAg-po

A low proportion of HBeAg among HBsAg-positive pregnant women with known HIV status could suggest low perinatal transmission of HBV in Cameroon

✍ Anfumbom KW Kfutwah; Mathurin Cyrille Tejiokem; Richard Njouom 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 122 KB

538 IMPROVED PREDICTIVE VALUE FOR SUSTAI

538 IMPROVED PREDICTIVE VALUE FOR SUSTAINED IMMUNE CONTROL IN PEGINTERFERON ALFA-2A (40KD) (PEGASYS)-TREATED HBEAG-POSITIVE PATIENTS USING COMBINED HBSAG AND HBV DNA LEVELS AT WEEK 24

✍ T. Piratvisuth; H.L.Y. Chan; P. Marcellin; C. Wat; L. Regep; D. Messinger; H.-P. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 205 KB

Early on-treatment prediction of respons

Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels

✍ Vincent Rijckborst; Bettina E. Hansen; Yilmaz Cakaloglu; Peter Ferenci; Fehmi Ta 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 189 KB 👁 2 views

Ferenci is a consultant for, advises, is on the speakers' bureau of, and received grants from Roche. Dr. Janssen is a consultant for and received grants from Roche, Bristol-Myers Squibb, Schering-Plough, Novartis, and Gilead. Dr. Flisiak received grants from Roche.